Live Cases, Edited Cases and Lunch Symposiums Sponsored by the Industry

The participation of the medical industry is, undoubtedly, one of the most appealing aspects of the SOLACI-SOCIME 2018 Congress. As usual, the most important companies in this industry have decided to take part in our event. Their contribution is most valuable, as it brings relevance and improves the quality of our scientific presentations. Organize your schedule featuring the best live cases, edited cases and industry-sponsored symposiums!

Conferencias Magistrales

Live cases

August 1st | 09.45h – 11.00h | Main arena

WIN@SOLACI Live Cases from Instituto Nacional de Cardiología (INC) TERUMO and OCCLUTECH-SIEMENS HEALTHINEERS

 

August 1st | 15.00h – 16.30h | Main Arena 

Live Cases from Instituto Nacional de Cardiología (INC) PHILIPS-EDWARDS

 

August 2nd | 09.45h – 11.00h | Main Arena 

Live Cases 5 and 6 from Hospital 20 de Noviembre. MEDTRONIC

 

August 2nd | 15.00h – 16.30h | Main Arena 

Live Cases SOLACI-SOCIME from Hospital 20 de Noviembre

 

August 3rd | 09.45h – 11.00h | Main Arena 

Live Cases from CMN Siglo XXI. Medtronic and Philips

 

August 3rd | 15.00h – 16.30h | Main Arena 

Live Cases SOLACI-SOCIME from CMN La Raza

 

Edited cases

August 1st | 11.10h – 12.25h | Cases room 

11:10h-11:25h – MICROPORT Case

11:25h-11:40h – Lifetech Case

11:40h-11:55h – IHT Case

 

Sponsored Lunch Symposiums

August 1st | 13.30h – 15.00h | Main arena

Lunch Symposium Sponsored by ABBOTT: “Mitral Valve Disease”

 

August 1st | 13.30h – 15.00h | Coronary room

Lunch Symposium Sponsored by ABBOTT: “CTO in my Clinic: a Starting Point”

 

August 1st | 13.30h – 15.00h | Pediatric Room

Lunch Symposium Sponsored by DDM: “20 years of Amplatzer in Mexico and Latin America

 

August 2nd | 13.30h – 15.00h | Main arena

Lunch Symposium Sponsored by ABBOTT: “Challenging Interventionism”

 

August 2nd | 13.30h – 15.00h | Coronary room

Lunch Symposium Sponsored by TERUMO: “Simplifying the complex by Radial”

 

August 2nd | 13.30h – 15.00h | Structural and peripheral room

Lunch Symposium Sponsored by PHILIPS: “Optimizing PCI results with iFR/FFR,IVUS and SyncVision”

 

August 2nd | 13.30h – 15.00h | Pediatric room 

Lunch Symposium Sponsored by OCCLUTECH “Occlutech Perfecting Performance”

 

August 3rd | 13.30h – 15.00h | Structural and peripheral room

Lunch Symposium Sponsored by BOSTON SCIENTIFIC

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...